The study found that the released HMGB1 formed complexes with pro-interleukin-1-beta (pro-IL-1β) in both human and mouse plasma, and this heterocomplexes were able to induce immune dysfunction in LBI (57). The gene discussed is IL1B; the disease is immune system disorder.